Upcoming Meetings: FDA Anesthesiology and Respiratory Therapy Devices Panel
This article was originally published in The Gray Sheet
Executive Summary
FDA Anesthesiology and Respiratory Therapy Devices Panel: Slated to convene at 11 a.m. on Sept. 20 to discuss development of a guidance document on 510(k) submissions "for continuous positive air way pressure devices for treatment of obstructive sleep apnea," according to the agency's advisory committee information line. The panel also will hear presentations on FDA's 510(k) exemption of approximately 40 anesthesiology and respiratory therapy devices ("The Gray Sheet" Jan. 22, p. 6). FDA staffers note that there has been uncertainty as to whether certain devices are covered by the exemption or should be considered accessories to Class III products. The agency also wishes to obtain input on situations in which devices may technically meet the definition for exemption but nevertheless represent novel technologies that require FDA review. The meeting will take place at FDA offices at 9200 Corporate Blvd. in Rockville, Maryland. For further information, contact FDA's Michael Bazaral at 301/443-8609...
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.